Quest Diagnostics Insider Trades
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 10 · $14.42M
- Shares bought / sold
- 0 / 64.72K
- Net activity
- Net selling $14.4 million
Quest Diagnostics insider activity
Over the last 12 months, Quest Diagnostics insiders reported 52 transactions on SEC Form 4: 0 open-market purchases and 10 sales. Insiders bought $0 and sold $14.4 million worth of stock, for net insider selling of $14.4 million. The largest seller was PREVOZNIK MICHAEL E, with $6.3 million in reported sales.
The most recent filing shows Davis J. E. (CEO and President) selling 10,000 shares at $242.72 on Sep 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DGX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
DGX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 1, 2026 | Davis J. E.CEO and President | Sale | 10,000 | $2.43M | Form 4 |
| Aug 28, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Gift | 1,000 | — | Form 4 |
| Aug 28, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Sale | 430 | $105.14K | Form 4 |
| Aug 28, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Sale | 6,237 | $1.52M | Form 4 |
| Aug 28, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Sale | 16,010 | $3.89M | Form 4 |
| Aug 28, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Option exercise | 22,677 | $2.54M | Form 4 |
| Jul 28, 2026 | DELANEY MARK ESVP & Chief Commercial Officer | Sale | 1,600 | $376.29K | Form 4 |
| Jul 22, 2026 | DELANEY MARK ESVP & Chief Commercial Officer | other | 34 | $7.03K | Form 4 |
| Jul 22, 2026 | KUPPUSAMY KARTHIKSVP, Clinical Solutions | other | 37 | $7.65K | Form 4 |
| Jul 22, 2026 | Lassiter Wright IIIDirector | other | 6 | $1.24K | Form 4 |
| Jul 22, 2026 | SAMAD SAMExecutive Vice President & CFO | Award | 102 | $21.09K | Form 4 |
| Jul 22, 2026 | MAIN TIMOTHY LDirector | other | 21 | $4.34K | Form 4 |
| Jul 22, 2026 | Plewman PatrickSVP for Diagnostic Services | other | 46 | $9.51K | Form 4 |
| Jul 22, 2026 | Gregg Vicky BDirector | Award | 72 | $14.89K | Form 4 |
| Jul 22, 2026 | CARTER ROBERT BDirector | other | 11 | $2.27K | Form 4 |
| Jun 4, 2026 | KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | 8,147 | $1.63M | Form 4 |
| Jun 4, 2026 | KUPPUSAMY KARTHIKSVP, Clinical Solutions | Option exercise | 4,827 | $587.95K | Form 4 |
| Jun 4, 2026 | KUPPUSAMY KARTHIKSVP, Clinical Solutions | Option exercise | 3,320 | $424.05K | Form 4 |
| Jun 1, 2026 | Davis J. E.CEO and President | Sale | 10,000 | $1.94M | Form 4 |
| May 20, 2026 | Lassiter Wright IIIDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | RING TIMOTHY MDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | Gregg Vicky BDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | PFEIFFER GARY MDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | MORRISON DENISE MDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | Doi TraceyDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | WENTWORTH TIMOTHY CDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | MAIN TIMOTHY LDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | Diaz LuisDirector | Award | 1,142 | — | Form 4 |
| May 20, 2026 | CARTER ROBERT BDirector | Award | 1,142 | — | Form 4 |
| Apr 20, 2026 | CARTER ROBERT BDirector | other | 7 | $1.36K | Form 4 |
| Apr 20, 2026 | Gregg Vicky BDirector | Award | 68 | $13.24K | Form 4 |
| Apr 20, 2026 | Plewman PatrickSVP for Diagnostic Services | other | 49 | $9.54K | Form 4 |
| Apr 20, 2026 | DELANEY MARK ESVP & Chief Commercial Officer | other | 37 | $7.20K | Form 4 |
| Apr 20, 2026 | KUPPUSAMY KARTHIKSVP, Clinical Solutions | other | 39 | $7.59K | Form 4 |
| Apr 20, 2026 | Lassiter Wright IIIDirector | other | 6 | $1.17K | Form 4 |
| Apr 20, 2026 | SAMAD SAMExecutive Vice President & CFO | Award | 108 | $21.03K | Form 4 |
| Mar 9, 2026 | WENTWORTH TIMOTHY CDirector | Award | 215 | — | Form 4 |
| Mar 5, 2026 | Plewman PatrickSVP for Diagnostic Services | Sale | 2,855 | $588.73K | Form 4 |
| Mar 5, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Sale | 3,878 | $799.68K | Form 4 |
| Mar 5, 2026 | Doherty Catherine T.EVP, Regional Businesses | Sale | 5,558 | $1.15M | Form 4 |
| Mar 4, 2026 | Plewman PatrickSVP for Diagnostic Services | Tax withholding | 2,827 | $579.14K | Form 4 |
| Mar 4, 2026 | Plewman PatrickSVP for Diagnostic Services | Award | 5,682 | $1.16M | Form 4 |
| Mar 4, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Tax withholding | 3,354 | $687.10K | Form 4 |
| Mar 4, 2026 | PREVOZNIK MICHAEL ESVP & General Counsel | Award | 7,232 | $1.48M | Form 4 |
| Mar 4, 2026 | DELANEY MARK ESVP & Chief Commercial Officer | Tax withholding | 2,326 | $476.50K | Form 4 |
| Mar 4, 2026 | DELANEY MARK ESVP & Chief Commercial Officer | Award | 5,682 | $1.16M | Form 4 |
| Mar 4, 2026 | Doherty Catherine T.EVP, Regional Businesses | Tax withholding | 5,806 | $1.19M | Form 4 |
| Mar 4, 2026 | Doherty Catherine T.EVP, Regional Businesses | Award | 11,364 | $2.33M | Form 4 |
| Mar 4, 2026 | Davis J. E.CEO and President | Tax withholding | 26,414 | $5.41M | Form 4 |
| Mar 4, 2026 | Davis J. E.CEO and President | Award | 51,652 | $10.58M | Form 4 |
| Mar 4, 2026 | SAMAD SAMExecutive Vice President & CFO | Tax withholding | 7,720 | $1.58M | Form 4 |
| Mar 4, 2026 | SAMAD SAMExecutive Vice President & CFO | Award | 13,947 | $2.86M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4